Provided by Tiger Trade Technology Pte. Ltd.

Praxis Precision Medicines, Inc.

295.51
+8.603.00%
Post-market: 295.510.00000.00%19:44 EDT
Volume:456.10K
Turnover:134.35M
Market Cap:8.23B
PE:-22.97
High:298.56
Open:290.13
Low:286.00
Close:286.91
52wk High:392.70
52wk Low:50.31
Shares:27.85M
Float Shares:24.08M
Volume Ratio:0.97
T/O Rate:1.89%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.8634
EPS(LYR):-13.4758
ROE:-38.86%
ROA:-25.65%
PB:6.14
PE(LYR):-21.93

Loading ...

Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants

GlobeNewswire
·
Jun 22

Movement Alert|Praxis Precision Medicines Rises 5.02% in Regular Trading, Trading at $283.05

Market Focus
·
Jun 19

Praxis Precision Medicines' Share Pullback Represents Good Entry Point, RBC Says

MT Newswires Live
·
Jun 18

RBC Initiates Praxis Precision Medicines at Outperform, Speculative Risk With $449 Price Target

MT Newswires Live
·
Jun 18

Movement Alert|Praxis Precision Medicines Rises 5.29% in Regular Trading, Trading at $271.2

Market Focus
·
Jun 17

Praxis Precision Medicines (PRAX) Stock After Vormatrigine POWER1 Miss And POWER2 Pause How Does Valuation Stack Up

Simply Wall St.
·
Jun 15

Praxis Precision Medicines Shareholders Back Directors and Governance

TIPRANKS
·
Jun 13

Praxis Precision Medicines shareholders elect three Class III directors at annual meeting

Reuters
·
Jun 13

Movement Alert|Praxis Precision Medicines Rises 5.81% in Regular Trading, Trading at $262.38

Market Focus
·
Jun 12

Praxis Precision Medicines (PRAX) Is Down 6.3% After Mixed Vormatrigine POWER1 Data Release - What's Changed

Simply Wall St.
·
Jun 12

Movement Alert|Praxis Precision Medicines Rises 5.02% in Regular Trading, Trading at $249.57

Market Focus
·
Jun 12

Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Amylyx Pharmaceuticals Inc (AMLX) and Cullinan Management (CGEM)

TIPRANKS
·
Jun 08

Praxis Precision Medicines to present at Goldman Sachs Global Healthcare Conference

Reuters
·
Jun 05

Movement Alert|Praxis Precision Medicines Falls 5.17% in Regular Trading, Continued Fallout from Core Epilepsy Trial Primary Endpoint Failure

Market Focus
·
Jun 04

Movement Alert|Praxis Precision Medicines Rises 5.31% in Regular Trading, Positive Secondary Endpoint Data Drives Rebound After Primary Endpoint Failure

Market Focus
·
Jun 03

Movement Alert|Praxis Precision Medicines Rises 5.7% in Pre-Market Trading, Secondary Endpoint Data and Safety Profile Drive Rebound After Prior Selloff

Market Focus
·
Jun 03

Movement Alert|Praxis Precision Medicines Rises 7.39% Overnight, Secondary Endpoint Positive Data Drives Rebound After Primary Endpoint Failure

Market Focus
·
Jun 03

Movement Alert|Praxis Precision Medicines Falls 8.94% in After-Hours Trading, Core Epilepsy Clinical Trial Fails to Meet Primary Endpoint

Market Focus
·
Jun 03

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Heron Therapeutics (HRTX) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Jun 03

Praxis Precision Medicines grants 2,754 RSUs to 13 new employees under 2024 inducement plan

Reuters
·
Jun 03